Nexalin Technology Stock Probability Of Bankruptcy

NXL Stock  USD 2.16  0.18  7.69%   
Nexalin Technology's odds of distress is over 50% at the moment. It has a moderate probability of going through some financial crisis in the next 2 years. Nexalin Technology's Odds of financial distress is determined by interpolating and adjusting Nexalin Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the Nexalin balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Nexalin Technology Piotroski F Score and Nexalin Technology Altman Z Score analysis.
For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.
  
The value of Market Cap is estimated to slide to about 15.2 M. The Enterprise Value is projected to slide to about 15.4 M

Nexalin Technology Company odds of financial distress Analysis

Nexalin Technology's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Nexalin Technology Probability Of Bankruptcy

    
  Over 54%  
Most of Nexalin Technology's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nexalin Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Nexalin Technology probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Nexalin Technology odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Nexalin Technology financial health.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.83)
Revenue Per Share
0.018
Quarterly Revenue Growth
0.323
Return On Assets
(1.23)
Return On Equity
(2.21)
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Nexalin Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Nexalin Technology is extremely important. It helps to project a fair market value of Nexalin Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Nexalin Technology's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nexalin Technology's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nexalin Technology's interrelated accounts and indicators.
0.960.88-0.58-0.720.080.25-0.161.0-0.390.780.87-0.820.990.760.760.99-0.930.43
0.960.98-0.71-0.83-0.170.26-0.410.95-0.610.820.97-0.80.980.770.820.98-0.970.57
0.880.98-0.84-0.91-0.310.37-0.550.87-0.760.871.0-0.810.930.820.880.94-0.980.68
-0.58-0.71-0.840.940.32-0.730.57-0.560.88-0.84-0.850.83-0.65-0.87-0.85-0.670.81-0.73
-0.72-0.83-0.910.940.21-0.670.46-0.70.78-0.88-0.920.85-0.76-0.91-0.89-0.770.86-0.8
0.08-0.17-0.310.320.210.220.950.10.73-0.2-0.31-0.18-0.040.09-0.26-0.080.23-0.43
0.250.260.37-0.73-0.670.220.00.24-0.40.610.39-0.740.250.810.590.25-0.370.54
-0.16-0.41-0.550.570.460.950.0-0.130.89-0.43-0.540.11-0.27-0.19-0.48-0.320.47-0.56
1.00.950.87-0.56-0.70.10.24-0.13-0.360.760.86-0.820.990.750.740.98-0.910.41
-0.39-0.61-0.760.880.780.73-0.40.89-0.36-0.71-0.770.49-0.49-0.58-0.74-0.530.7-0.74
0.780.820.87-0.84-0.88-0.20.61-0.430.76-0.710.88-0.840.810.91.00.83-0.90.84
0.870.971.0-0.85-0.92-0.310.39-0.540.86-0.770.88-0.810.920.820.890.93-0.970.71
-0.82-0.8-0.810.830.85-0.18-0.740.11-0.820.49-0.84-0.81-0.82-0.97-0.82-0.820.85-0.53
0.990.980.93-0.65-0.76-0.040.25-0.270.99-0.490.810.92-0.820.770.81.0-0.960.49
0.760.770.82-0.87-0.910.090.81-0.190.75-0.580.90.82-0.970.770.890.77-0.830.7
0.760.820.88-0.85-0.89-0.260.59-0.480.74-0.741.00.89-0.820.80.890.82-0.890.87
0.990.980.94-0.67-0.77-0.080.25-0.320.98-0.530.830.93-0.821.00.770.82-0.970.51
-0.93-0.97-0.980.810.860.23-0.370.47-0.910.7-0.9-0.970.85-0.96-0.83-0.89-0.97-0.62
0.430.570.68-0.73-0.8-0.430.54-0.560.41-0.740.840.71-0.530.490.70.870.51-0.62
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Nexalin Technology has a Probability Of Bankruptcy of 54%. This is 24.74% higher than that of the Health Care Equipment & Supplies sector and 31.16% higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 35.58% lower than that of the firm.

Nexalin Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nexalin Technology's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nexalin Technology could also be used in its relative valuation, which is a method of valuing Nexalin Technology by comparing valuation metrics of similar companies.
Nexalin Technology is currently under evaluation in probability of bankruptcy category among its peers.

Nexalin Technology Main Bankruptcy Drivers

202020212022202320242025 (projected)
Return On Assets(29.4)(8.17)(0.26)(1.28)(1.8)(1.89)
Asset Turnover2.050.190.180.03050.040.038
Gross Profit Margin0.880.850.730.770.780.53
Net Debt647.6K188.3K592.5K(575.8K)(574.5K)(545.8K)
Total Current Liabilities1.6M2.4M1.9M425.3K546.7K1.1M
Total Assets118.5K753.7K7.4M3.6M4.2M3.0M
Total Current Assets116.9K752.7K7.4M3.4M4.0M2.9M
Total Cash From Operating Activities(863.5K)(1.1M)(2.2M)(3.8M)(3.9M)(3.7M)

Nexalin Technology ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nexalin Technology's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nexalin Technology's managers, analysts, and investors.
Environmental
Governance
Social

Nexalin Fundamentals

About Nexalin Technology Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nexalin Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nexalin Technology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nexalin Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nexalin Technology is a strong investment it is important to analyze Nexalin Technology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexalin Technology's future performance. For an informed investment choice regarding Nexalin Stock, refer to the following important reports:
Check out Nexalin Technology Piotroski F Score and Nexalin Technology Altman Z Score analysis.
For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.83)
Revenue Per Share
0.018
Quarterly Revenue Growth
0.323
Return On Assets
(1.23)
Return On Equity
(2.21)
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.